Gene expression profiling of the irinotecan pathway in colorectal cancer

Jinsheng Yu, William D. Shannon, Mark A. Watson, Howard L. McLeod

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

The exact mechanism responsible for large variation of response to chemotherapy remains unclear. This study profiled the gene expression for the entire irinotecan pathway to provide insights into individualized cancer therapy. The RNA expressions of 24 irinotecan pathway genes were measured in paired tumor and normal tissues from 52 patients with Dukes' C colorectal cancer using a real-time quantitative reverse transcription-PCR assay. The relative expression levels across the 24 pathway genes varied considerably, with a 441-fold range from highest to lowest expression levels for the tumor tissues and a 934-fold range for the normal tissaes. Interpatient variability was also quite large, with a 33.6 median fold change in the tumor tissue genes and a 30.1 median fold change in the normal tissue genes. Six of the 24 irinotecan pathway genes had dramatically lower expression levels in the tumor samples than did the genes in the normal tissues (median range, 1.28-4.39 folds; P = 0.001-0.029). Eight genes had significantly higher levels (median range, 1.35-2.42 folds; P = 0.001-0.011). Using hierarchical clustering, three gene clusters and three patient groups were observed with high similarity indices by the RNA expressions in colorectal tumors. The three patient groups had no unique clinical pathologic features but could be differentiated by the statistically significant differences in RNA expression level of seven genes. Our study indicates that gene expression profiling could be valuable for predicting tumor response to chemotherapy and for tailoring therapy to individual cancer patients.

Original languageEnglish
Pages (from-to)2053-2062
Number of pages10
JournalClinical Cancer Research
Volume11
Issue number5
DOIs
StatePublished - Mar 1 2005

Fingerprint

Dive into the research topics of 'Gene expression profiling of the irinotecan pathway in colorectal cancer'. Together they form a unique fingerprint.

Cite this